Oncolytics Biotech® Participates in Fireside Chats at Key Investment Conferences
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, has made an important announcement. This September, the Chief Financial Officer Kirk Look will take part in significant fireside chats at two prominent investment conferences.
Insights on Immunotherapy Innovations
Kirk Look will be sharing insights on the advancements in immunotherapy and its application in oncology. The company's participation is expected to draw attention from investors and analysts alike.
Key Details of the Conferences
- Conference One: Date and specifics to be announced.
- Conference Two: Date and specifics to be announced.
Investors are encouraged to stay tuned for more updates on these pivotal discussions.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.